EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT

NCT07695311 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma
Desmoplastic Small Round Cell Tumor

Interventions

DRUG: EWSR1 immunotherapy
DRUG: Pembrolizumab

Sponsor

Rabi Hanna

Collaborators

[object Object]